With our staff now numbering more than 50 and monitoring equipment in place, a range of studies is now underway.
Studies are now underway
Some recent initial client comments:-“It is wonderful to work from bright, friendly and newly refurbished premises”“Very practical layout”“Has a very good atmosphere
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
